Jiangxi Fushine Pharmaceutical Co.,Ltd.’s Net Profit Dropped 82.4% in First Three Quarters of 2022

Jiangxi Fushine Pharmaceutical Co.,Ltd. (江西富祥药业股份有限公司) (300497.SZ) reported a net profit of 27.6 million yuan in the first three quarters of 2022, down 82.4% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, up 15.6% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 43.5%.